Adtalem Global Education Inc.

Greetings and welcome to the Atelum Global Education Third Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note, this conference is being recorded. I will now turn the conference over to your host, Jay Spitzer, Vice President of Investor Relations. Thank you. You may begin.

Good afternoon, and welcome to our earnings call for the third quarter fiscal year 2025 results. On the call with me today are Steve Beard, Chairman and Chief Executive Officer of AdTalent Global Education, and Bob Phelan, Chief Financial Officer. Before I hand you over to Steve, I will, as usual, take you through the legal, safe harbor, and cautionary declarations. Certain statements and projections of future results made in this presentation constitute as forward-looking statements that are based on our current market, competitive, and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We undertake no obligation to update publicly any forward-looking statement after this presentation as a result of new information, future events, changes in assumption, or otherwise. Please see our latest Form 10-K, Form 10-Q for discussion of risk factors as related to forward-looking statements. In today's presentation, we'll use certain non-GAAP financial measures. We refer you to the pendants of the presentation materials available on our Investor Relations website for reconciliations to the most directly comparable GAAP financial measures and related information. You can find a link to our webcast on our investor relations website at investors.adtalum.com. After this call, the presentation webcast will be archived on the website for 30 days. I will now hand you over to Steve.

Thanks, Jay. Good afternoon, everyone, and thank you for joining us. At Atalum, our innovative model, steadfast commitment to access, and growth with purpose strategy are driving exceptional performance and delivering transformative results. As patient populations surge and clinical workforce shortages deepen, our mission to shape the future of healthcare education has never been more urgent or impactful. Our third quarter results reflect this momentum. Revenue grew by 13% to $466 million. Total enrollment climbed to 9.8% year over year, marking seven consecutive quarters of growth, with over 94,000 students now choosing Ad Talem institutions. Adjusted EBITDA margin expanded by 150 basis points, fueling a 28% surge in adjusted earnings per share to $1.92. Now let's dive into our segment performance and strategic progress. Chamberlain University, the nation's largest nursing school, continues its strong trajectory. Enrollment rose 6.8% to over 40,000 students. Our BSN online program, now available in 36 states with 53 clinical hubs, has surpassed 3,000 students, bringing nursing education to urban and rural communities alike. Our practice-ready specialty-focused program is transforming nursing education by providing early hands-on exposure to high-demand specialties. Importantly, this program has been developed in partnership with leading healthcare providers. Since its inception, over 4,000 students have enrolled with 900 completing specialty rotations across 70 plus partner sites. This innovative program allows students to explore high value specialties like perioperative nursing during their clinical training, ensuring that they're well prepared for their chosen path. Graduates who pursue these specialties are highly sought after by our partner health systems. Walden University achieved a remarkable 13.5% enrollment increase, reaching 48,500 students, exceeding pre-pandemic levels. Our Get the W campaign paired with digital innovations has boosted inquiries and conversion rates. Predictive analytics and advanced learning tools are enhancing retention and academic outcomes. This spring, Walden's 72nd commencement celebrated 6,000 graduates, including 2,500 nurses, and 2,100 social, behavioral, and health professionals, proof of our ability to deliver talent where it's needed most. Our medical and veterinary segment returned to growth with enrollment up 1.2%, and we believe that our two medical schools, AUC and RossMed, are positioned for long-term growth. Our deepened partnership with Hippocratic AI is pioneering AI-driven curricula, enabling future physicians to elevate care quality. And for the fourth consecutive year, AUC and RossMed achieved a 95% plus first-time residency attainment rate, placing over 615 students in over 325 healthcare facilities. Critically, over 40% of these placements are in medically underserved areas, addressing a projected US physician shortfall of 187,000 by the year 2037. Ross Vet, operating near capacity, secured the nation's top spots for graduates matched into selective internships and residencies. And based on this collective strength, we're raising our 2025 guidance. We now expect revenue of $1.76 billion to $1.775 billion. And we expect adjusted EPS of $6.40 to $6.60. Our robust cash flow and strong balance sheet enabled us to complete our $300 million share repurchase program. And we subsequently announced a new $150 million repurchase program through May of 2028, underscoring our confidence in our strategic outlook. At TALIM aims to change the face of healthcare for a better tomorrow. Our growth with purpose strategy rooted in integrity, relentless execution, and disciplined innovation creates lasting value for students, partners, and shareholders. Demand for our programs in nursing, medicine, mental health, and veterinary sciences isn't just strong, it's growing. Students choose us because we empower them to build meaningful careers that change lives. Looking ahead, we're investing to expand program capacity, and doubling down on innovation to meet this demand. Our commitment is clear. Deliver operational excellence, drive shareholder value, and lead the charge in building the healthcare workforce of tomorrow. The market is recognizing our vision. Our strategy is delivering. Our future is brighter than ever. And with that, I'll turn it over to Bob for a deeper dive into our financials.